BNVI, BUSE, DSCO, DTPI, EMMS, ENCY Have Also Been Added To Naked Short List Today.

0 Comments | M2 Presswire, April, 2008

M2 PRESSWIRE-2 April 2008-BUYINS.NET: BNVI, BUSE, DSCO, DTPI, EMMS, ENCY Have Also Been Added To Naked Short List Today(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:02042008

BUYINS.NET, www.buyins.net.

Bionovo Inc. (NASDAQ: BNVI) engages in the discovery and development of drugs in the areas of cancer and women's health primarily in the United States. It develops drugs to treat breast and ovarian cancers, and for menopause. The company's product and drug pipeline includes MF101, a selective estrogen receptor beta agonist, which is in Phase II trial to alleviate the symptoms of menopause, including hot flashes, night sweats, and bone mineral loss; and BZL101, an apoptosis inducing factor translocator/activator, which completed Phase I clinical...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)